Inventor · disambiguated record
Mark Bodmer
Also filed as: BODMER MARK · BODMER MARK W · BODMER MARK WILLIAM
14 granted patents·18 pending applications·2,885 citations·filing 1988–2022
95Inventor score
Files withEVELO BIOSCIENCES INC8CELLTECH THERAPEUTICS LTD6BODMER MARK W3CELLTECH LTD3CELLTECH R&D LTD2
Top patents by PatentIndex Score
32 records- 0198US5677425ARecombinant antibodyCELLTECH THERAPEUTICS LTD·Filed 1994·Granted Oct 14, 1997·1k cites·13 claims
- 0297US5994510ARecombinant antibodies specific for TNFαCELLTECH THERAPEUTICS LTD·Filed 1995·Granted Nov 30, 1999·233 cites·3 claims
- 0397US5877293ACDR grafted anti-CEA antibodies and their productionCELLTECH THERAPEUTICS LTD·Filed 1995·Granted Mar 2, 1999·537 cites·9 claims
- 0496US6180377B1Humanized antibodiesCELLTECH THERAPEUTICS LTD·Filed 1993·Granted Jan 30, 2001·473 cites·17 claims
- 0595US5219996ARecombinant antibodies and methods for their production in which surface residues are altered to cysteine residues for attachment of effector or receptor moleculesCELLTECH LTD·Filed 1988·Granted Jun 15, 1993·315 cites·10 claims
- 0694US5958413AUse of antibodies to TNF or fragments derived thereof and xanthine derivatives for combination therapy and compositions thereforCELLTECH LTD·Filed 1997·Granted Sep 28, 1999·197 cites·23 claims
- 0779US6734286B2Interleukin-5 specific recombinant antibodiesCELLTECH R&D LTD·Filed 2001·Granted May 11, 2004·9 cites·7 claims
- 0878USRE39548EInterleukin-5 specific recombinant antibodiesCELLTECH R&D LTD·Filed 2001·Granted Apr 3, 2007·4 cites·7 claims
- 0976US5965405AMethod for producing Fv fragments in eukaryotic cellsCELLTECH LTD·Filed 1993·Granted Oct 12, 1999·34 cites·10 claims
- 1065US5998586AInterleukin-5 specific recombinant antibodiesCELLTECH THERAPEUTICS LTD·Filed 1995·Granted Dec 7, 1999·17 cites·4 claims
- 1163US2022211773A1Compositions and methods for treating immune disorders using immune modulating lactococcus bacteria strainsEVELO BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1258US2025114411A1Solid dosage forms containing bacteria and microbial extracellular vesiclesEVELO BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1356US6316227B1Nucleic acids encoding interleukin-5 specific recombinant antibodiesCELLTECH THERAPEUTICS LTD·Filed 1999·Granted Nov 13, 2001·9 cites·8 claims
- 1455US2023277603A1Veillonella parvula strain as an oral therapy for neuroinflammatory diseasesEVELO BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 1555US2022249579A1Secreted microbial extracellular vesiclesEVELO BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 1654US2022296654A1Processed microbial extracellular vesiclesEVELO BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 1753US11266700B2Compositions and methods for treating immune disorders using immune modulating Lactococcus bacteria strainsEVELO BIOSCIENCES INC·Filed 2018·Granted Mar 8, 2022·0 cites·13 claims
- 1851US6013642AUse of estrone derivatives as steroid sulphatase inhibitorsFiled 1995·Granted Jan 11, 2000·19 cites·5 claims
- 1945US6315999B1Pharmaceutical product for the treatment of sepsisSOLVAY·Filed 1994·Granted Nov 13, 2001·12 cites·13 claims
- 2045US2005220886A1Modulators of the Notch signalling pathway and uses thereof in medical treatmentBODMER MARK W·Filed 2004·Application pending·0 cites
- 2144US2003199679A1Recombinant antibodies specific for TNF-alphaFiled 2003·Application pending·0 cites
- 2244US2005026831A1Medical treatmentFiled 2004·Application pending·0 cites
- 2344US2005137130A1Medical treatmentFiled 2004·Application pending·0 cites
- 2443US2022339208A1Compositions and methods of treating psoriasis and atopic dermatitis using prevotella histicolaEVELO BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 2543US2005025751A1Modulators of Notch signalling for use in immunotherapyFiled 2004·Application pending·0 cites
- 2640US2006205823A1Treatment of allergic diseases using a modulator of the Notch signaling pathwayBODMER MARK W·Filed 2005·Application pending·0 cites
- 2740US2005059093A1Method for detecting modulators of Notch signallingFiled 2004·Application pending·0 cites
- 2838US2019314427A1Methods of treating cancer using parabacteroidesEVELO BIOSCIENCES INC·Filed 2017·Application pending·0 cites
- 2938US2004213797A1Conjugates for the modulation of immune responsesFiled 2004·Application pending·0 cites
- 3034US2006002924A1Conjugate of notch signalling pathway modulators and their use in medical treatmentBODMER MARK W·Filed 2005·Application pending·0 cites
- 3133US2010303867A1a composition comprising a notch ligand and an allergenb or allergen bystander antigenBODMER MARK WILLIAM·Filed 2010·Application pending·0 cites
- 3220US2001056582A1Paired mutationsFiled 1998·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Bodmer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →